IDiyas

For the Inventor, By the Inventor

Wuppertal, Germany

Nicole Diedrichs

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 8.1

ph-index = 7

Forward Citations = 181(Granted Patents)


Location History:

  • Wuppertal, DE (2006 - 2012)
  • Velbert, DE (2010 - 2015)

Company Filing History:

goldMedal5 out of 721 
 
Bayer Intellectual Property Gmbh
 patents
silverMedal4 out of 192 
 
Bayer Schering Pharma Ag
 patents
bronzeMedal3 out of 12,157 
 
Bayer Aktiengesellschaft
 patents
4. 2 out of 76 
 
Bayer Healthcare Aktiengesellschaft
 patents
5. 1 out of 22 
 
Xention Limited
 patents

Years Active: 2006-2015

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 8957017 - Dipeptoid prodrugs and their use (2015-02-17),
2. 8703934 - Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof (2014-04-22),
3. 8703696 - Dipeptoid prodrugs and the use thereof (2014-04-22),
4. 8691850 - Substituted phenylaminothiazoles and use thereof (2014-04-08),
5. 8242281 - Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands (2012-08-14),
6. 8030347 - Cylopenta[b]benzofuran derivatives and the utilization thereof (2011-10-04),
7. 7855219 - Substituted 2-oxy-3,5-dicyano-4aryl-6-aminopyridines and use thereof (2010-12-21),
8. 7825255 - Adenosine receptor selective modulators (2010-11-02),
9. 7709504 - Use of Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting (2010-05-04),
10. 7683076 - Tetrahydro-quinolinylurea derivatives (2010-03-23),
11. 7615557 - Tetrahydro-naphthalene and urea derivatives (2009-11-10),
12. 7129255 - Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor (2006-10-31),
13. 7109218 - Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same (2006-09-19),
14. 7078417 - Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations (2006-07-18),
15. 7045631 - Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands (2006-05-16),

Title: Nicole Diedrichs: Pioneering Innovation in Pharmaceutical Prodrugs

Introduction:

Nicole Diedrichs, a visionary inventor hailing from Wuppertal, Germany, is a shining example of relentless dedication to innovation. With 15 patents to her name, Diedrichs stands as a testament to the power of perseverance and forward-thinking in the realm of pharmaceuticals.

Latest Patents:

Among her notable patents is the groundbreaking work on "Dipeptoid Prodrugs and Their Use." This application focuses on prodrug derivatives tailored for the treatment and prophylaxis of cardiovascular disorders. Diedrichs' research underscores her commitment to advancing medical solutions that address critical health challenges.

Career Highlights:

Diedrichs has made significant contributions to renowned companies such as Bayer Intellectual Property GmbH and Bayer Schering Pharma AG. Her expertise and ingenuity have been instrumental in driving innovation within the pharmaceutical industry, shaping the landscape of modern healthcare.

Collaborations:

Throughout her career, Diedrichs has collaborated with esteemed professionals, including Thomas Krahn and Ulrich Rosentreter. These partnerships have fostered a collaborative spirit, sparking creativity and fostering a culture of excellence in research and development.

Conclusion:

In conclusion, Nicole Diedrichs' remarkable journey exemplifies the transformative impact of innovation and dedication in shaping the world of tomorrow. Her pioneering work in pharmaceutical prodrugs not only showcases her technical prowess but also serves as an inspiration for aspiring inventors worldwide. Diedrichs' legacy underscores the profound influence of individuals who dare to think boldly and push the boundaries of what is possible in the realm of inventions and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…